Europe (WHO region) vs Palestine, State of: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Europe (WHO region)
89.0%
in 2025
Palestine, State of
99.0%
in 2025
Europe (WHO region) rank
3rd
Palestine, State of rank
1st
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Europe (WHO region)
- Palestine, State of
How they compare
Palestine, State of currently reports 99.0% against 89.0% in Europe (WHO region), a difference of 10.0%.
That makes Palestine, State of's figure about 1.1 times Europe (WHO region)'s.
Across all 26 years both countries report, Palestine, State of has been ahead every year.
Europe (WHO region) ranks 3rd and Palestine, State of ranks 1st of 11 groups.
Palestine, State of has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Palestine, State of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70.6% | 94.2% | 23.6% | Palestine, State of |
| 2010s | 87.3% | 97.8% | 10.5% | Palestine, State of |
| 2020s | 89.5% | 96.3% | 6.8% | Palestine, State of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Europe (WHO region) or Palestine, State of?
- Palestine, State of, at 99.0% against 89.0% in Europe (WHO region) as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Europe (WHO region) and Palestine, State of?
- 10.0%, with Palestine, State of ahead.
- How many years of comparable data are there for Europe (WHO region) and Palestine, State of?
- 26 years are reported by both, from 2000 to 2025.
- How do Europe (WHO region) and Palestine, State of rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Europe (WHO region) ranks 3rd and Palestine, State of ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.